| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |